The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Postpubertal Emergence of Hyperresponsiveness to Stress and to Amphetamine after Neonatal Excitotoxic Hippocampal Damage: A Potential Animal Model of Schizophrenia
Abstract
The constellation of major phenomena associated with schizophrenia (e.g., postpubertal onset, congenital hippocampal area damage, cortical functional deficits, limbic dopamine (DA) dysregulation, and vulnerability to stress) have been difficult to explain with a unitary animal model. Although it has been shown that rats develop increased mesolimbic DA transmission and reduced cortical DA turnover following adult excitotoxic lesions of the ventral hippocampus (VH), the implications of early developmental VH lesions are not known. To determine the developmental sequelae of such changes, we produced ibotenic acid lesions of the ventral hippocampal formation in rats on the 7th day after birth (PD7). Motor activity in a novel environment, after saline injection and after d-amphetamine administration were similar in control and lesioned rats at PD35. However, in early adulthood, at PD56, animals with the hippocampal lesion were hyperactive in each of these conditions. The emergence of the hyperactivity at PD56 could be prevented by pretreatment with haloperidol. Moreover, rats lesioned as neonates, in contrast to a similar lesion induced in adult animals, were also hyperresponsive to stress evaluated with a swim test. This latter effect is analogous to that seen after adult lesions of the medial prefrontal cortex, rather than after adult lesions of VH, suggesting that the neonatal VH lesion may affect functional development of the medial prefrontal cortex. These results demonstrate…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These are primarily based on pharmacological lesions of the developing hippocampus, such as the prenatal exposure to methylazoxymethanol acetate (MAM) and the neonatal ventral hippocampal lesion (NVHL) models 55,56 .”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [55]
In the citing paper
“Both models reproduce some of the defects observed in schizophrenia, including functional deficits in PV+ fast spiking interneurons.”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [55]
Citations
Cites
Dopamine in schizophrenia: a review and reconceptualization
Davis, K. L., Kahn, R. S., Ko, G., & Davidson, M. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.11.1474 · Cited by 2,051
Factors That Predict Individual Vulnerability to Amphetamine Self-Administration
Piazza, P. V., Deminière, J.-M., Moal, M. L., & Simon, H. (1989) · Science · doi:10.1126/science.2781295 · Cited by 1,355
Bogerts, B. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790310046006 · Cited by 880
Groenewegen, H. J., Vermeulen‐Vanderzee, E., Kortschot, A. T., & Witter, M. P. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90275-2 · Cited by 867
Goldman‐Rakic, P. S., Selemon, L. D., & Schwartz, M. L. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90166-0 · Cited by 782
Kelley, A. E., & Domesick, V. B. (1982) · Neuroscience · doi:10.1016/0306-4522(82)90198-1 · Cited by 746
Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats
PYCOCK, C., Kerwin, R. W., & Carter, C. J. (1980) · Nature · doi:10.1038/286074a0 · Cited by 550
Development of the dopaminergic innervation in the prefrontal cortex of the rat
Kalsbeek, A., Voorn, P., Buijs, R. M., Pool, C. W., & Uylings, H. B. M. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902690105 · Cited by 545
Cerebral Glucography With Positron Tomography
Buchsbaum, M. S. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290030001001 · Cited by 535
Sesack, S. R., & Pickel, V. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)91146-8 · Cited by 439
Flagged first, then by citations
1 of the 34 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–300 of 697
A Candidate Molecule Approach to Defining Developmental Pathology in Schizophrenia
Weickert, C. S., & Weinberger, D. R. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033327 · Cited by 57
Self-citationRisterucci, C., Jeanneau, K., Schöppenthau, S., Bielser, T., Künnecke, B., von Kienlin, M., & Moreau, J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2204-8 · Cited by 56
PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756
Abi‐Dargham, A., Simpson, N. R., Kegeles, L. S., Parsey, R. V., Hwang, D., Anjilvel, S., Zea‐Ponce, Y., Lombardo, I., Heertum, R. V., Mann, J. J., et al. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199905)32:2 · Cited by 115
Self-citationLack of effect of an early stressful life event on sensorimotor gating in adult rats
Lehmann, J., Pryce, C. R., & Feldon, J. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00080-8 · Cited by 56
Paulus, M. P., Bakshi, V. P., & Geyer, M. A. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00158-7 · Cited by 56
Pharmacotherapy for schizophrenia and co-occurring substance use disorders
Noordsy, D. L., & Green, A. I. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0066-5 · Cited by 55
Kalkman, H. O., & Loetscher, E. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0826-8 · Cited by 55
A Role for Oxytocin in the Etiology and Treatment of Schizophrenia
Rich, M. E., & Caldwell, H. K. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00090 · Cited by 60
Could Stress Cause Psychosis in Individuals Vulnerable to Schizophrenia?
Corcoran, C. M., Mujica-Parodi, L. R., Yale, S. A., Leitman, D., & Malaspina, D. (2002) · CNS Spectrums · doi:10.1017/s1092852900022240 · Cited by 57
Bringas, M. E., Morales‐Medina, J. C., Flores-Vivaldo, Y., Negrete‐Díaz, J. V., Aguilar‐Alonso, P., León‐Chávez, B. A., Lazcano-Ortiz, Z., Monroy, E., Moreno, A. R., Quirion, R., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.008 · Cited by 54
Berg, S. A., Sentir, A. M., Cooley, B. S., Engleman, E. A., & Chambers, R. A. (2013) · Addiction Biology · doi:10.1111/adb.12082 · Cited by 54
Clozapine and GABA transmission in schizophrenia disease models
O'Connor, W. T., & O’Shea, S. D. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.005 · Cited by 58
Uehara, T., Sumiyoshi, T., Seo, T., Matsuoka, T., Itoh, H., Suzuki, M., & Kurachi, M. (2010) · Brain Research · doi:10.1016/j.brainres.2010.07.013 · Cited by 53
Cognitive impairments in the STOP null mouse model of schizophrenia.
Powell, K. J., Hori, S. E., Leslie, R. A., Andrieux, A., Schellinck, H. M., Thorne, M., & Robertson, G. S. (2007) · Behavioral Neuroscience · doi:10.1037/0735-7044.121.5.826 · Cited by 62
Clifton, N. E., Morisot, N., Girardon, S., Millan, M. J., & Loiseau, F. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2845-3 · Cited by 57
Ashe, P. C., Chlan‐Fourney, J., Juorio, A. V., & Li, X. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03176-1 · Cited by 53
Dopaminergic sensitization: Implications for the pathogenesis of schizophrenia
Glenthoj, B. Y., & Hemmingsen, R. (1997) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(96)00158-3 · Cited by 54
O’Donnell, P. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.07.005 · Cited by 53
L’hypothèse neurodéveloppementale dans la schizophrénie
Gourion, D., Gourévitch, R., Provost, J.-B. L., Olié, J., Lôo, H., & Krebs, M. (2004) · L Encéphale · doi:10.1016/s0013-7006(04)95421-8 · Cited by 52
Emerging Opportunities for Antipsychotic Drug Discovery in the Postgenomic Era
Marino, M. J., Knutsen, L. J. S., & Williams, M. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701094q · Cited by 52
El-Khodor, B., & Boksa, P. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00228-7 · Cited by 49
Krüger, H., Brockmann, M. D., Salamon, J., Ittrich, H., & Hanganu‐Opatz, I. L. (2012) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2012.04.001 · Cited by 52
Vaid, R. R., Yee, B. K., Shalev, U., Rawlins, J. N. P., Weiner, I., Feldon, J., & Totterdell, S. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05599.1997 · Cited by 53
Risk Factors for Schizophrenia: From Conception to Birth
McGrath, J. J., & Murray, R. M. (2003) · doi:10.1002/9780470987353.ch13 · Cited by 52
Terranova, J.-P., Chabot, C., Barnouin, M. C., Perrault, G., Depoortère, R., Griebel, G., & Scatton, B. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2268-5 · Cited by 51
Palmer, A. A., Brown, A. S., Keegan, D. A., Siska, L. D., Susser, E., Rotrosen, J., & Butler, P. D. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.089 · Cited by 51
Dean, D. J., Orr, J. M., Bernard, J. A., Gupta, T., Pelletier‐Baldelli, A., Carol, E. E., & Mittal, V. A. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv086 · Cited by 55
Flore, G., Ruberto, G. D., Parisot, J., Sannino, S., Russo, F., Illingworth, E. A., Studer, M., & Leonibus, E. D. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhv336 · Cited by 52
Walter, A., Suenderhauf, C., Harrisberger, F., Lenz, C., Smieskova, R., Chung, Y., Cannon, T. D., Bearden, C. E., Rapp, C., Bendfeldt, K., et al. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.10.007 · Cited by 56
Repeated subchronic exposure to phencyclidine elicits excessive atypical grooming in rats
Audet, M., Goulet, S., & Doré, F. Y. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.08.026 · Cited by 51
Prefrontal lesion reverses abnormal mesoaccumbens response in an animal model of schizophrenia
Goto, Y., & O’Donnell, P. (2004) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00783-2 · Cited by 51
Neonatal exposure to phenobarbital potentiates schizophrenia-like behavioral outcomes in the rat
Bhardwaj, S. K., Forcelli, P. A., Palchik, G. A., Gale, K., Srivastava, L. K., & Kondratyev, A. D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.02.001 · Cited by 50
Brady, A. M., Saul, R. D., & Wiest, M. K. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.08.012 · Cited by 50
Daenen, E. W. P. M., Wolterink, G., Gerrits, M. A. F. M., & van Ree, J. M. (2002) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00350-3 · Cited by 50
Christensen, B. K., & Bilder, R. M. (2000) · The Canadian Journal of Psychiatry · doi:10.1177/070674370004500303 · Cited by 51
Chowdhury, T. G., Ríos, M. B., Chan, T. E., Cassataro, D., Barbarich-Marsteller, N. C., & Aoki, C. J. (2014) · Hippocampus · doi:10.1002/hipo.22320 · Cited by 49
Cotter, D. (1995) · Schizophrenia Research · doi:10.1016/0920-9964(94)e0082-i · Cited by 48
Fatemi, S. H., Sidwell, R. W., Kist, D. A., Akhter, P., Meltzer, H. Y., Bailey, K. W., THURAS, P. D., & Sedgwick, J. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00450-8 · Cited by 49
Exploring the Dendritic Spine Pathology in a Schizophrenia-related Neurodevelopmental Animal Model
Tendilla‐Beltrán, H., Vázquez‐Roque, R. A., Vázquez-Hernández, A. J., Garcés‐Ramírez, L., & Flores, G. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.11.006 · Cited by 50
Neuroimaging findings from childhood onset schizophrenia patients and their non-psychotic siblings
Ordóñez, A. E., Luscher, Z. I., & Gogtay, N. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.03.003 · Cited by 50
Alquicer, G., Gómez, A. B. S., Peralta, F., & Flores, G. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2003.12.003 · Cited by 48
Chambers, R. A., & Taylor, J. R. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.05.019 · Cited by 48
Pathogenesis of schizophrenia: Part II. Temporo‐frontal two‐step hypothesis
Kurachi, M. (2003) · Psychiatry and Clinical Neurosciences · doi:10.1046/j.1440-1819.2003.01073.x · Cited by 48
Neonatal Isolation Alters LTP in Freely Moving Juvenile Rats: Sex Differences
Bronzino, J. D., Kehoe, P. G., Austin-LaFrance, R. J., Rushmore, J., & Kurdian, J. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(96)00166-9 · Cited by 48
Affective Reactivity of Symptoms as a Process Discriminator in Schizophrenia
Docherty, N. M. (1996) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199609000-00004 · Cited by 48
Alterations in Postnatal Neurogenesis and Dopamine Dysregulation in Schizophrenia: A Hypothesis
Inta, D., Meyer‐Lindenberg, A., & Gass, P. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq134 · Cited by 47
Logical fallacies in animal model research
Sjoberg, E. A. (2017) · Behavioral and Brain Functions · doi:10.1186/s12993-017-0121-8 · Cited by 54
Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less
Swerdlow, N. R., Halim, N. A., Hanlon, F. M., Platten, A., & Auerbach, P. P. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00492-0 · Cited by 47
Hippocampal Volume Development in Healthy Siblings of Childhood-Onset Schizophrenia Patients
Mattai, A. A., Hosanagar, A., Weisinger, B., GREENSTEIN, D. K., Stidd, R., CLASEN, L. S., Lalonde, F. M., Rapoport, J. L., & Gogtay, N. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10050681 · Cited by 46
Bardgett, M. E., Jackson, J. L., Taylor, G. T., & Csernansky, J. G. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(95)80005-0 · Cited by 46
Lee, H., Dvořák, D., & Fenton, A. A. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00015 · Cited by 45
Kupferschmidt, D. A., & Gordon, J. A. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818771821 · Cited by 46
Risperidone Pretreatment Prevents Elevated Locomotor Activity Following Neonatal Hippocampal Lesions
Richtand, N. M., Taylor, B., Welge, J. A., Ahlbrand, R., Ostrander, M. M., Burr, J., Hayes, S., Coolen, L. M., Pritchard, L. M., Logue, A., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300791 · Cited by 45
Blink rate, neurocognitive impairments, and symptoms in schizophrenia
Chen, E. Y. H., Lam, L. C. W., Chen, R. Y. L., & Nguyen, D. G. H. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00482-3 · Cited by 45
Consciousness is for other people
Frith, C. (1995) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00040474 · Cited by 44
Reduced N-acetylaspartate in prefrontal cortex of adult rats with neonatal hippocampal damage.
Bertolino, A., Roffman, J., Lipska, B., van Gelderen, P., Olson, A. W., & Weinberger, D. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.9.983 · Cited by 46
Millan, M. J., & Brocco, M. (2008) · Therapies · doi:10.2515/therapie:2008041 · Cited by 44
Tendilla‐Beltrán, H., Meneses-Prado, S., Vázquez‐Roque, R. A., Rodríguez, M. T., Vázquez-Hernández, A. J., Coatl-Cuaya, H., Martín‐Hernández, D., MacDowell, K. S., Garcés‐Ramírez, L., Leza, J. C., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1249-19.2019 · Cited by 45
Hanlon, F. M., & Sutherland, R. J. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(99)00114-x · Cited by 44
Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia
Brady, A. M., McCallum, S. E., Glick, S. D., & O’Donnell, P. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1195-7 · Cited by 43
Tseng, K. Y., Amin, F., Lewis, B. L., & O’Donnell, P. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.030 · Cited by 43
Belujon, P., Patton, M. H., & Grace, A. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhs380 · Cited by 43
Cellular and circuit models of increased resting-state network gamma activity in schizophrenia
White, R. S., & Siegel, S. J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.011 · Cited by 44
Biomarkers for Psychiatric Disorders
Turck, C. W. (2009) · Springer eBooks · doi:10.1007/978-0-387-79251-4 · Cited by 42
Developmental insanity or dementia praecox: was the wrong concept adopted?
O'Connell, P., Woodruff, P. W. R., Wright, I. C., Jones, P. B., & Murray, R. M. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00110-7 · Cited by 43
Lodge, D. J., & Perez, S. M. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s42708 · Cited by 42
Ethanol sensitization in a neurodevelopmental lesion model of Schizophrenia in rats
Conroy, S. K., Rodd, Z. A., & Chambers, R. A. (2006) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.07.017 · Cited by 42
Impaired Reality Testing in an Animal Model of Schizophrenia
McDannald, M. A., Whitt, J. P., Calhoon, G. G., Piantadosi, P. T., Karlsson, R., O’Donnell, P., & Schoenbaum, G. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.06.014 · Cited by 42
Does schizophrenia result from developmental or degenerative processes?
Church, S. M., Cotter, D., Bramon, E., & Murray, R. M. (2002) · Springer eBooks · doi:10.1007/978-3-7091-6137-1_8 · Cited by 42
Beninger, R. J., Jhamandas, A., Aujla, H., Xue, I. C., Dagnone, R., Boegman, R. J., & Jhamandas, K. H. (2002) · Neurotoxicity Research · doi:10.1080/10298420290031414 · Cited by 42
Lipska, B. K., & Weinberger, D. R. (1994) · Developmental Brain Research · doi:10.1016/0165-3806(94)90033-7 · Cited by 42
Self-citationGardner, R. J., Kersanté, F., Jones, M. W., & Bartsch, U. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12533 · Cited by 42
Neurodegeneration in schizophrenia
Archer, T. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.09.152 · Cited by 42
Al-Amin, H. A., Atweh, S., Jabbur, S. J., & Saadé, N. E. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03762.x · Cited by 41
Bhardwaj, S. K., Beaudry, G., Quirion, R., Lévesque, D., & Srivastava, L. K. (2003) · Neuroscience · doi:10.1016/j.neuroscience.2003.08.016 · Cited by 41
Brain inhibitory mechanisms involved in basic and higher integrated sleep processes
Gottesmann, C. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.003 · Cited by 41
Laplante, F., Stevenson, C. W., Gratton, A., Srivastava, L. K., & Quirion, R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02831.x · Cited by 40
Santos‐Silva, T., Fabris, D. D. S., de Oliveira, C. L., Guimarães, F. S., & Gomes, F. V. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad123 · Cited by 45
Paterson, C., & Law, A. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104172 · Cited by 38
Takase, K., Yamamoto, Y., & Yagami, T. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.04.016 · Cited by 40
Jeanblanc, J., Balguerie, K., Coune, F., Legastelois, R., Jeanblanc, V., & Naassïla, M. (2014) · Addiction Biology · doi:10.1111/adb.12146 · Cited by 40
Hunt, M. J., Kessal, K., & Garcia, R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3800-04.2005 · Cited by 41
DNA microarrays in neuropsychopharmacology
Marcotte, E. R., Srivastava, L. K., & Quirion, R. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01741-7 · Cited by 40
Hori, T., Subramaniam, S., Srivastava, L. K., & Quirion, R. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00059-9 · Cited by 40
Developmental markers of psychiatric disorders as identified by sensorimotor gating
Powell, S. B., & Geyer, M. A. (2002) · Neurotoxicity Research · doi:10.1080/10298420290030578 · Cited by 40
Tan, H. Y., Chen, A. G., Chen, Q., Browne, L. B., Verchinski, B. A., Kolachana, B. S., Zhang, F., Apud, J. A., Callicott, J. H., Mattay, V. S., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.91 · Cited by 39
Self-citationClinical correlates of hippocampus volume and shape in antipsychotic-naïve schizophrenia
Kalmady, S. V., Shivakumar, V., Arasappa, R., Subramaniam, A., Gautham, S., Venkatasubramanian, G., & Gangadhar, B. N. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.03.014 · Cited by 41
Effect of pre- versus post-weaning environmental disturbances on social behaviour in mice
Bouët, V., Lecrux, B., Tran, G., & Fréret, T. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.11.033 · Cited by 39
Laplante, F., Srivastava, L. K., & Quirion, R. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02351.x · Cited by 39
Significance of dysfunctional glutamatergic transmission for the development of psychotic symptoms.
Pietraszek, M. (2003) · PubMed · Cited by 39
Neonatal Insult to the Hippocampal Region and Schizophrenia: A Review and a Putative Animal Model
Beauregard, M., & Bachevalier, J. (1996) · The Canadian Journal of Psychiatry · doi:10.1177/070674379604100710 · Cited by 39
Berg, S. A., & CHAMBERS, R. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.03.011 · Cited by 38
Jongen‐Rêlo, A. L., Leng, A., Lüber, M., Pothuizen, H. H. J., Weber, L., & Feldon, J. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(03)00228-6 · Cited by 38
Levin, E. D., & Christopher, N. C. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.10.018 · Cited by 38
Richtand, N. M., Logue, A. D., Welge, J. A., Perdiue, J., Tubbs, L. J., Spitzer, R. H., Sethuraman, G., & Geracioti, T. D. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02247-2 · Cited by 38
The limits of neurophysiological models of consciousness
Velmans, M. (1995) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00040681 · Cited by 38
Mouri, A., Nagai, T., Ibi, D., & Yamada, K. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.025 · Cited by 38
Tomasella, E., Bechelli, L., Ogando, M. B., Mininni, C. J., Guilmi, M. N. D., Fino, F. D., Zanutto, S., Elgoyhen, A. B., Marín‐Burgin, A., & Gelman, D. M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1719897115 · Cited by 37
Behavioral Animal Models of Antipsychotic Drug Actions
Peleg‐Raibstein, D., Feldon, J., & Meyer, U. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_14 · Cited by 39
Cascella, N. G., Takaki, M., Lin, S. Y., & Sawa, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04628.x · Cited by 37
Metadata
- Authors
- Lipska, B. K., Jaskiw, G. E., & Weinberger, D. R.
- Affiliations
- National Institute of Mental Health (US)
- University Hospitals of Cleveland (US)
- Venue
- Neuropsychopharmacology
- Published
- 1993-08
- Volume
- 9
- Issue
- 1
- Pages
- 67-75
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2012245779
- Cited by
- 697
- References
- 34
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 2 · 2023: 5 · 2022: 10 · 2021: 14 · 2020: 12 · 2019: 10 · 2018: 8 · 2017: 13 · 2016: 19 · 2015: 22 · 2014: 26 · 2013: 19 · 2012: 30
- FWCI
- 21.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- schizophrenia, animal models of schizophrenia, ventral hippocampus, ibotenic acid, dopamine dysregulation, haloperidol
- MeSH terms
- Animals, Animals, Newborn, Dextroamphetamine, Disease Models, Animal, Female, Haloperidol, Hippocampus, Ibotenic Acid, Motor Activity, Pregnancy, Schizophrenia, Stress, Psychological, Swimming, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review